Patent Assignment
Reel/Frame 029196/0484
Assignment of Assignor's Interest
Recorded: 2012-10-26
Pages: 4
Assignors
YARRANTON, GEOFFREY T.
Executed: 2012-10-09
PALATH, VARGHESE
Executed: 2012-10-09
BEBBINGTON, CHRISTOPHER R.
Executed: 2012-10-09
BAER, MARK
Executed: 2012-10-23
Assignee
KALOBIOS PHARMACEUTICALS, INC.
260 E. GRAND AVENUE, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property
(1)
Methods of Treating Hematological Proliferative Disorders by Targeting EPHA3 Expressed on Aberrant Vasculature in Bone Marrow
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
May 23, 2016
From: KALOBIOS PHARMACEUTICALS, INC.
To: BLACK HORSE CAPITAL, LP
Reel/Frame 038788/0266 →
Security Interest
Dec 22, 2016
From: KALOBIOS PHARAMECUTICALS, INC.
To: BLACK HORSE CAPITAL MASTER FUND LTD.
Reel/Frame 041181/0605 →
Release of Security Interest
Mar 30, 2018
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: KALOBIOS PHARAMECUTICALS, INC.
Reel/Frame 045788/0148 →
Release of Security Interest
Mar 30, 2018
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: KALOBIOS PHARAMECUTICALS, INC.
Reel/Frame 045855/0533 →
Security Interest
Jul 16, 2019
From: HUMANIGEN, INC.
To: BLACK HORSE CAPITAL MASTER FUND LTD.
Reel/Frame 049769/0067 →
Change of Name
Jun 5, 2020
From: KALOBIOS PHARMACEUTICALS, INC.
To: HUMANIGEN, INC.
Reel/Frame 052858/0975 →
Release of Security Interest
Jun 12, 2020
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: HUMANIGEN, INC.
Reel/Frame 052920/0631 →